Host: Insect cells • Tag: N-terminal His • MW: 80.62 kDa
Related Products
Measurement and Detection Target(s)
25965PAD6 Monoclonal Antibody (Clone 4B7)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

PAD6 (human, recombinant)

Item No. 24615

Technical Information
Synonyms
  • PADI6
  • hPADVI
  • Peptidylarginine Deiminase 6
  • Protein-Arginine Deiminase Type-6
Purity
≥90% estimated by SDS-PAGE
Source
N-Terminal hexahistidine-tagged enzyme isolated from a baculovirus overexpression system
Amino Acids
717
MW
80.62 kDa
50 mM HEPES, pH 8.0, with 300 mM sodium chloride, 1 mM DTT, and 10% glycerol
UniProt Accession №
Q6TGC4
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Protein arginine deiminase 6 (PAD6) is a homodimeric guanidine-modifying enzyme belonging to the amidinotransferase superfamily.1 It is a calcium-dependent enzyme that catalyzes the post-translational modification of target proteins by converting arginine to citrulline. PAD6 is expressed in mammalian oocytes, sperm cells, and early embryos.2 In mammalian oocytes and early embryo cytoplasm, its expression is localized to cytoskeletal sheets, dynamic structures containing various keratins, which are major targets for citrullination. PAD6-/- oocytes exhibit reduced microtubule acetylation and defective organelle positioning and redistribution, suggesting a role for PAD6 in regulating microtubule-mediated organelle movement and positioning.3 PAD6-/- female, but not male, mice are infertile due to a reduction of de novo protein synthesis, cytoskeletal sheet formation, and ribosomal RNA which induces arrest of zygote development at the two-cell stage.2,4 PAD6 is regulated by newborn ovary homeobox (Nobox), as its promoter contains a Nobox DNA-binding element (NBE) and expression and activity of PAD6 are decreased in Nobox-/- mouse ovaries.5 In human females, homozygous nonsense mutations and compound-heterozygous mutations in PAD6 induce early embryonic arrest following in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bicker, K.L., and Thompson, P.R. The protein arginine deiminases: Structure, function, inhibition, and disease. Bioplymers 99(2), 155-163 (2013).

    2. Esposito, G., Vitale, A.M., Leijten, F.P., et alPeptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol. Cell Endocrinol. 273(1-2), 25-31 (2007).

    3. Kan, R., Yurttas, P., Kim, B., et alRegulation of mouse oocyte microtubule and organelle dynamics by PADI6 and the cytoplasmic lattices. Dev. Biol. 350(2), 311-322 (2011).

    4. Liu, X., Morency, E., Li, T., et alRole for PADI6 in securing the mRNA-MSY2 complex to the oocyte cytoplasmic lattices. Cell Cycle 16(4), 360-366 (2017).

    5. Choi, M., Lee, O.H., Jeon, S., et alThe oocyte-specific transcription factor, Nobox, regulates the expression of Pad6, a peptidylarginine deiminase in the oocyte. FEBS Lett. 584(16), 3629-3634 (2010).

    6. Xu, Y., Shi, Y., Fu, J., et alMutations in PADI6 cause female infertility characterized by early embryonic arrest. Am. J. Hum. Genet. 99(3), 744-752 (2016).